Rapid Street Reporting

Rapid Street Reporting (RSR) is a national venue-intercept study planned for the 17 NDEWS Sentinel Sites. Over the next five years, RSR will take place in at least six sentinel sites per year over a weekend period.

This initiative uses a modified version of Co-Investigator Dr. Joseph Palamar’s validated rapid survey, which has been previously used to survey over 4,500 nightclub attendees. The rapid survey is programmed to assess the use and correlates of use of over 100 drugs, many of which are new psychoactive substances (NPS), and queries whether users experienced acute adverse effects from specific drugs used.

Biological testing is important when investigating NPS, which is why NDEWS is adding hair testing of surveyed individuals. Dr. Palamar has been detecting extensive underreported NPS use via hair testing, as many individuals were unknowingly exposed through adulterated drugs. Specimens will be tested by Dr. Alberto Salomone with three published methods utilizing ultra-high performance liquid chromatography–tandem mass spectrometry (UHPLC-MS/MS). Two of these methods (developed by Dr. Salomone) are capable of detecting over 100 NPS––mostly synthetic cannabinoids, synthetic cathinones (“bath salts”), and now fentanyl analogs and other potent opioid NPS.

If you are interested in working as an interviewer for the RSR study, please contact the study coordinators Nae Won (nwon@ufl.edu) and Anna Wang (annawang@ufl.edu) for more details.

Past reports:

Miami, FL | Survey dates: November 3-5, 2023: NDEWS-2023-RSR0024

Philadelphia, PA | Survey dates: October 27-29, 2023: NDEWS-2023-RSR0023

Phoenix, AZ | Survey dates: September 22-24, 2023: NDEWS-2023-RSR0022

New York City | Survey dates: August 2527, 2023: NDEWS-2023-RSR0021

San Francisco | Survey dates: July 19–23, 2023: NDEWS-2023-RSR0020

Los Angeles, CA | Survey dates: July 19–23, 2023: NDEWS-2023-RSR0019

Denver, CO | Survey dates: June 16–17, 2023: NDEWS-2023-RSR0018

Detroit, MI | Survey Dates: April 79, 2023: NDEWS-2023-RSR0017

Chicago, IL | Survey Dates: March 2426, 2023: NDEWS-2023-RSR0016

Charlotte, NC | Survey Dates: February 24–26, 2023: NDEWS-2023-RSR0015

Austin, TX | Survey Dates: January 20-22, 2023: NDEWS-2023-RSR0014

Charleston, SC | Survey Dates: November 4–5, 2022: NDEWS-2022-RSR0013

Denver, CO | Survey Dates: October 21–23, 2022: NDEWS-2022-RSR0012

Philadelphia, PA | Survey Dates: September 23-25, 2022: NDEWS-2022-RSR0011

San Diego, CA | Survey Dates: August 19–21, 2022: NDEWS-2022-RSR00010

St. Louis, MO | Survey Dates: July 15-17, 2022: NDEWS-2022-RSR0009

Lexington, KY | Survey Dates: June 24-26,2022: NDEWS-2022-RSR0008

New York City, NY | Survey Dates: May 20-22, 2022: NDEWS-2022-RSR0007

Seattle, WA | Survey Dates: May 13-15, 2022: NDEWS-2022-RSR0006

Washington, DC | Survey Dates: April 15-17, 2022: NDEWS-2022-RSR0005

Gainesville, FL | Survey Date: April 9, 2022: NDEWS-2022-RSR004

Tampa, FL | Survey Dates: February 18-20, 2022: NDEWS-2022-RSR0003

Atlanta Metro Area | Survey Dates: January 28-30, 2022: NDEWS-2022-RSR0002

San Francisco Bay Area | Survey Dates: November 12-14, 2021: NDEWS-2021-RSR0001

Last modified: 01/05/2024

The National Drug Early Warning System (NDEWS) is funded by the National Institute on Drug Abuse (U01DA051126) to the University of Florida (PI: Cottler; Co-Is: Goldberger, Nixon, Striley), New York University (Co-I: Palamar), and Florida Atlantic University (Co-I: Barenholtz).